|
Featuring an embodied AI brain, long-term memory, and natural language interaction, EBO Max brings a new level of awareness and companionship to modern homes.
SHENZHEN, China, March 31, 2026 /PRNewswire/ -- Enabot, a pioneer in family companion robotics, today announced the launch of EBO Max, its most advanced home robot to date. Powered by a new AI brain, EBO Max is designed to think, learn, and adapt within the home—bringing intelligent assistance, family companionship, and home monitoring into a single mobile device.
At the core of EBO Max is an upgraded AI brain capable of multimodal perception, contextual understanding, and long-term memory. By combining vision, voice, and environmental awareness, the robot can interpret situations and make dynamic decisions while carrying out tasks in the home.
Unlike traditional smart cameras or voice assistants, EBO Max is built to move. With intelligent navigation, it can locate family members or pets, check different areas of the home, and identify potential changes or unusual activity.
It is also capable of executing multi-step tasks with minimal input. Users can assign tasks remotely, interact through voice, and receive personalized reminders. The robot can also perform scheduled or condition-based tasks, adapting to different daily scenarios.
Designed for everyday family life, EBO Max supports a wide range of real-world use cases. Users can connect via two-way video, check in on loved ones, monitor pets, or receive alerts when something changes at home, such as possible falls. With 4K imaging, it can also capture important moments and provide timely reminders based on routines.
Over time, EBO Max builds familiarity with its environment through long-term memory, allowing it to respond more naturally and efficiently as it learns household patterns.
With its combination of mobility, AI intelligence, and human-centered design, EBO Max reflects Enabot's vision of creating robots that not only assist—but naturally integrate into the home.
The EBO Max is available for pre-order at $549.99 ($50 OFF) on the Enabot website.
About Enabot
Enabot believes our lives can be improved by intelligent family bots. Our vision of a technology-driven world is positive, with robots being part of the solutions to daily problems, allowing people to focus their time on what matters the most: to be there for the ones we love. By connecting people, we are dedicated to promoting love, companionship and sharing.
Discover more about Enabot here.
Featuring an embodied AI brain, long-term memory, and natural language interaction, EBO Max brings a new level of awareness and companionship to modern homes.
SHENZHEN, China, March 31, 2026 /PRNewswire/ -- Enabot, a pioneer in family companion robotics, today announced the launch of EBO Max, its most advanced home robot to date. Powered by a new AI brain, EBO Max is designed to think, learn, and adapt within the home—bringing intelligent assistance, family companionship, and home monitoring into a single mobile device.
At the core of EBO Max is an upgraded AI brain capable of multimodal perception, contextual understanding, and long-term memory. By combining vision, voice, and environmental awareness, the robot can interpret situations and make dynamic decisions while carrying out tasks in the home.
Unlike traditional smart cameras or voice assistants, EBO Max is built to move. With intelligent navigation, it can locate family members or pets, check different areas of the home, and identify potential changes or unusual activity.
It is also capable of executing multi-step tasks with minimal input. Users can assign tasks remotely, interact through voice, and receive personalized reminders. The robot can also perform scheduled or condition-based tasks, adapting to different daily scenarios.
Designed for everyday family life, EBO Max supports a wide range of real-world use cases. Users can connect via two-way video, check in on loved ones, monitor pets, or receive alerts when something changes at home, such as possible falls. With 4K imaging, it can also capture important moments and provide timely reminders based on routines.
Over time, EBO Max builds familiarity with its environment through long-term memory, allowing it to respond more naturally and efficiently as it learns household patterns.
With its combination of mobility, AI intelligence, and human-centered design, EBO Max reflects Enabot's vision of creating robots that not only assist—but naturally integrate into the home.
The EBO Max is available for pre-order at $549.99 ($50 OFF) on the Enabot website.
About Enabot
Enabot believes our lives can be improved by intelligent family bots. Our vision of a technology-driven world is positive, with robots being part of the solutions to daily problems, allowing people to focus their time on what matters the most: to be there for the ones we love. By connecting people, we are dedicated to promoting love, companionship and sharing.
Discover more about Enabot here.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Enabot Introduces EBO Max, an AI-Powered Family Robot Designed to Think, Learn, and Care
|
A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products.
TORONTO, March 31, 2026 /PRNewswire/ -- Dalton Pharma Services today announced the successful installation of its RoboFil™ aseptic powder fill-finish system at its Toronto, Canada facility. This fully automated, isolator-based platform expands Dalton's aseptic powder fill-finish capacity and further strengthens the company's position as a market leader.
Dalton's RoboFil™ line is purpose-built for aseptic powder fill-finish programs where dose accuracy, process consistency, and sterility assurance are paramount. By combining robotic handling with isolator technology, the platform helps minimize the needs for operator interventions, a primary contamination risk in aseptic operations, while enabling rapid, efficient changeovers between vial formats. This flexibility supports both development-stage batches through to repeatable GMP production campaigns.
Dr. Jixing Wang, President of Dalton Pharma Services, said:
"RoboFil™ reflects Dalton's commitment to investing in advanced technologies that enable our clients to execute aseptic powder fill-finish with confidence. This Annex 1–aligned robotic isolator platform expands both our capacity and our operational flexibility, supporting programs from early clinical supply through scalable commercial manufacturing."
About Dalton Pharma Services: Dalton Pharma Services is a full-service Contract Development and Manufacturing Organization (CDMO) based in Toronto, Canada. With 37 years of proven performance, Dalton's single-site model integrates API development and cGMP manufacturing, formulation, aseptic fill/finish, and in-house QC/microbiological testing under a unified Quality Management System (QMS). Powered by a globally diverse team representing 40+ nationalities, including 44 MS/PhDs, and supported by 3,000+ successful production campaigns, Dalton partners with biotech and pharmaceutical companies worldwide to accelerate life-enhancing therapies from development through commercial supply.
For more information, visit: Dalton Website
Media Contact
Muhammad Haris
Marketing Manager
mharis@dalton.com
A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products.
TORONTO, March 31, 2026 /PRNewswire/ -- Dalton Pharma Services today announced the successful installation of its RoboFil™ aseptic powder fill-finish system at its Toronto, Canada facility. This fully automated, isolator-based platform expands Dalton's aseptic powder fill-finish capacity and further strengthens the company's position as a market leader.
Dalton's RoboFil™ line is purpose-built for aseptic powder fill-finish programs where dose accuracy, process consistency, and sterility assurance are paramount. By combining robotic handling with isolator technology, the platform helps minimize the needs for operator interventions, a primary contamination risk in aseptic operations, while enabling rapid, efficient changeovers between vial formats. This flexibility supports both development-stage batches through to repeatable GMP production campaigns.
Dr. Jixing Wang, President of Dalton Pharma Services, said:
"RoboFil™ reflects Dalton's commitment to investing in advanced technologies that enable our clients to execute aseptic powder fill-finish with confidence. This Annex 1–aligned robotic isolator platform expands both our capacity and our operational flexibility, supporting programs from early clinical supply through scalable commercial manufacturing."
About Dalton Pharma Services: Dalton Pharma Services is a full-service Contract Development and Manufacturing Organization (CDMO) based in Toronto, Canada. With 37 years of proven performance, Dalton's single-site model integrates API development and cGMP manufacturing, formulation, aseptic fill/finish, and in-house QC/microbiological testing under a unified Quality Management System (QMS). Powered by a globally diverse team representing 40+ nationalities, including 44 MS/PhDs, and supported by 3,000+ successful production campaigns, Dalton partners with biotech and pharmaceutical companies worldwide to accelerate life-enhancing therapies from development through commercial supply.
For more information, visit: Dalton Website
Media Contact
Muhammad Haris
Marketing Manager
mharis@dalton.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Dalton Pharma Services Expands Aseptic Powder Fill-Finish Capacity with RoboFil™ system in Toronto
